Address
Healthcare Ventures LLC
55 Cambge Parkway
Suite 301
Cambridge, MA 02142
United States
Phone
Website
Recent investment activity
KANDO id: 20584
Corporate information
Founders
Official name
Healthcare Ventures LLC
Registration country
Company type
Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage.Funding rounds
Actual initial investment stage
N/A (2)
Investment activity status
Active investor
Selected investments
Displaying 76 - 100 of 123| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
PreCision Dermatology Inc | Develops, manufactures, acquires and markets dermatology products | N/A | |||
|
|
Premier Pharmacy | Operation of Hospital-based Pharmacies | N/A | |||
|
|
Principia Pharmaceutical Corp | Develops and distributes biopharmaceutical products for chronic diseases, using molecular engineering and protein manufacturing technologies. | N/A | |||
|
|
Procept Inc | N/A | ||||
|
|
Progen Pharmaceuticals Inc | Develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. | N/A | |||
|
|
Promedior Inc | A biotechnology company developing novel biologic therapeutics to treat fibroproliferative diseases. | N/A | |||
|
|
ProScript Inc | Discovers, researches, and develops compounds to treat cachexia focusing on muscle-wasting associated with cancer. | N/A | |||
|
|
Proteostasis Therapeutics Inc | N/A | ||||
|
|
Radius Health Inc | A biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of osteoporosis | N/A | |||
|
Replidyne Inc | Biopharmaceutical company, engages in discovering, developing, in-licensing, and commercializing anti-infective products. | N/A | |||
|
|
Seahorse Bioscience Inc | A developer of test and measurement equipment that is primarily used for cell assay tests in research laboratories. | N/A | |||
|
|
Sequoia Pharmaceuticals Inc | Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. | N/A | |||
|
|
Shape Pharmaceuticals Inc | N/A | ||||
|
|
Shire Pharmaceuticals Group Ltd | N/A | ||||
|
|
Sierra Neuropharmaceuticals Inc | Engages in the development and commercialization of centrally-administered small molecule therapeutics for the treatment of CNS diseases. | N/A | |||
|
|
STC Technologies Inc | Engages in the development, manufacture, and marketing of in vitro diagnostic products and medical devices for use in clinical laboratories | N/A | |||
|
|
Stemgent Inc | Developer of a technology and application solutions for the advancement of stem cell research. | N/A | |||
|
|
Synovex Corp | N/A | ||||
|
|
Tensha Therapeutics Inc | N/A | ||||
|
|
TetraLogic Pharmaceuticals | A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. | Series B | |||
|
|
Theraclone Sciences Inc | Series B | ||||
|
|
Theraclone Sciences Inc | N/A | ||||
|
|
Thios Pharmaceuticals Inc | Engages in the discovery, development, and commercialization of small molecule and antibody therapeutics. | N/A | |||
|
|
Threshold Pharmaceuticals Inc | N/A | ||||
|
|
Tolerx Inc | Developer of a novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. | N/A |